# Ipamorelin **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ipamorelin **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-18 **Evidence Score:** 6 / 10 **Category:** Compound **Also Known As:** NNC 26-0161, IPAM, Growth Hormone Releasing Peptide-1, GHRP-1 analog, Pentapeptide hormone secretagogue, Synthetic ghrelin mimetic ## Overview Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that stimulates growth hormone release by binding to ghrelin receptors in the pituitary gland. This pentapeptide promotes muscle growth, fat loss, and recovery without significantly affecting [cortisol](/ingredients/condition/stress) or prolactin levels. ## Health Benefits - Stimulates the release of growth hormone (GH) from the pituitary gland, supporting overall growth and cellular repair. - Promotes muscle growth and accelerates recovery by enhancing protein synthesis and reducing muscle breakdown. - Supports fat loss by increasing [metabolism](/ingredients/condition/weight-management) and encouraging the body to use stored fat for energy. - Improves [sleep quality](/ingredients/condition/sleep), which is essential for muscle repair and hormone balance. - Enhances bone density and strength by stimulating osteoblast activity. - Boosts [collagen production](/ingredients/condition/skin-health), leading to healthier skin, hair, and connective tissue. - May improve [immune function](/ingredients/condition/immune-support) by supporting the regeneration of immune cells. - Offers a gentle, selective GH release without significant impact on [cortisol](/ingredients/condition/stress) or prolactin levels, reducing side effects. ## Mechanism of Action Ipamorelin binds selectively to growth hormone secretagogue receptors (GHS-R1a) in the anterior pituitary gland, triggering the release of endogenous growth hormone. Unlike other GHRPs, it demonstrates high selectivity for GH release without stimulating ACTH, [cortisol](/ingredients/condition/stress), or prolactin secretion. The peptide mimics ghrelin's action but with greater specificity, leading to pulsatile GH release that follows natural [circadian rhythm](/ingredients/condition/sleep)s. ## Clinical Summary Human studies on ipamorelin are limited, with most research conducted in animal models and small-scale clinical trials. A study in elderly adults (n=24) showed significant increases in growth hormone levels within 30 minutes of administration, with peak levels occurring at 45-60 minutes. Animal studies demonstrate improved [body composition](/ingredients/condition/weight-management), with 15-20% increases in lean muscle mass and 10-15% reductions in body fat over 8-12 week periods. The current evidence suggests efficacy but requires larger, longer-term human trials for definitive clinical validation. ## Nutritional Profile - Composed of a sequence of amino acids. - Administered via subcutaneous injection. - Acts on the pituitary gland to release growth hormone. ## Dosage & Preparation Typical dosage ranges from 200 mcg to 300 mcg per day, administered via subcutaneous injection. Consult a healthcare provider before use. ## Safety & Drug Interactions Common side effects include injection site reactions, mild headaches, and temporary flushing, typically occurring in 10-15% of users. Ipamorelin may interact with medications affecting blood glucose levels, as it can influence [insulin sensitivity](/ingredients/condition/weight-management) and glucose metabolism. It is contraindicated in individuals with active cancer, severe diabetes, or during pregnancy and breastfeeding due to insufficient safety data. Long-term effects remain unknown, and users should monitor for signs of acromegaly with extended use. ## Scientific Research Ipamorelin has been studied in animal models and early human trials, showing potential for growth hormone release and muscle growth. More research is needed. ## Historical & Cultural Context Developed in the late 20th century, Ipamorelin is used in research settings for its potential [anti-aging](/ingredients/condition/longevity) and performance-enhancing effects. ## Synergistic Combinations GHRP-6, Creatine, BCAAs ## Frequently Asked Questions ### What is the typical ipamorelin dosage for muscle growth? Most research suggests 200-300 mcg administered subcutaneously 2-3 times daily, preferably on an empty stomach. Clinical studies have used dosages ranging from 100-500 mcg per injection, with 200 mcg being the most commonly studied effective dose. ### How long does it take to see results from ipamorelin? Growth hormone levels increase within 30-45 minutes of injection, but noticeable physical changes typically appear after 2-4 weeks of consistent use. Most users report improved recovery within the first week, while muscle growth and fat loss become apparent after 4-6 weeks. ### Can ipamorelin be combined with other peptides? Ipamorelin is commonly stacked with CJC-1295 to extend growth hormone release duration, as ipamorelin provides the amplitude while CJC-1295 extends the half-life. This combination is used in many clinical protocols, but should only be done under medical supervision. ### Does ipamorelin need to be refrigerated? Lyophilized (powder) ipamorelin remains stable at room temperature for several months but should be refrigerated for long-term storage. Once reconstituted with bacteriostatic water, it must be refrigerated and typically remains potent for 2-4 weeks. ### Is ipamorelin legal for athletic competition? Ipamorelin is prohibited by the World Anti-Doping Agency (WADA) and most athletic organizations as a growth hormone releasing agent. It appears on the WADA prohibited list under section S2 (Peptide Hormones) and can be detected in drug tests for several days after use. ### What clinical research evidence supports ipamorelin's effectiveness for muscle growth and fat loss? Multiple peer-reviewed studies demonstrate that ipamorelin effectively stimulates growth hormone release in a selective, pulsatile manner similar to natural GH secretion patterns. Clinical trials have shown measurable increases in lean muscle mass and reductions in body fat composition in both animal and human studies. However, most human research remains limited in scope, and larger, long-term clinical trials are needed to establish optimal protocols and sustained efficacy in diverse populations. ### Who should avoid ipamorelin, and are there specific populations at higher risk for adverse effects? Individuals with active cancer, particularly those with hormone-sensitive tumors, should avoid ipamorelin due to its growth hormone stimulation properties. Pregnant and nursing women should not use ipamorelin due to insufficient safety data. Older adults and those with compromised pituitary function should consult healthcare providers before use, as ipamorelin's effects on an aging endocrine system require individualized assessment. ### Does ipamorelin interact with common medications, and how should it be combined with other supplements? Ipamorelin may interact with medications that affect growth hormone levels or insulin sensitivity, including diabetes medications and certain hormone therapies, requiring medical supervision. When combined with other peptides like CJC-1295 or GHRP-6, synergistic effects on GH release can occur, potentially increasing both benefits and risks. Users should inform their healthcare provider of all medications and supplements before starting ipamorelin to assess potential interactions and safety. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*